Circulation

It’s Time for Artificial Intelligence to Go Red For Women ^®

A Rocky Road to Research and Self-Discovery: A Conversation With Emelia J. Benjamin

Go(ing) Red for Women and Fulfilling Our Commitment to Sex-Based Reporting of Cardiovascular Disease

Expanding Opportunities for Women in Clinical Trials Leadership

Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk tha...

Association of Maternal Smoking During Pregnancy With Childhood Blood Pressure and Hypertension in the ECHO Cohort

Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women

BACKGROUND: Cardiovascular disease (CVD) prevalence is rising among younger women in the United States. Hypertensive disorders of pregnancy (HDP) are early indicators of cardiovasc...

Breast Cancer Reveals Latent <i>BMPR2</i> -Related Susceptibility to Pulmonary Hypertension

BACKGROUND: Pulmonary arterial hypertension (PAH) and breast cancer disproportionately affect women. BMPR2 (bone...

Polycystic Ovarian Syndrome and the Long-Term Risk of Arrhythmias

BACKGROUND: Polycystic ovarian syndrome (PCOS) is associated with increased cardiovascular morbidity and a higher risk of atherosclerotic cardiovascular disease. PCOS has been asso...

Aortic Dissection in Women With Turner Syndrome: Impact of Revised Guidelines on Incidence—A Nationwide Register-Based Cohort Study, 2001–2023

Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials

Redefining Cardiovascular Medicine: The Journey From “Does Sex Matter?” to “How Does Sex Matter?”

Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study

BACKGROUND: Discontinuing statin therapy before pregnancy remains challenging, especially in high-risk women. We evaluated the risks of maternal cardiovascular, gestational, and fe...